To the right are documents and evidence from the FDA Notices of Judgment Collection. These files contain information on incidences in which the federal government prosecuted manufactures and seized products under authority of the 1906 Pure Food and Drug Act, which required drugs sold in the United States to meet the standards of strength, quality and purity in the United States Pharmacopoeia and the National Formulary. A number of these cases were for the adulteration and misbranding of goods that did not meet the standards set forth in the United States Pharmacopeia and the National Formulary. Click/Touch the links on the right to explore some specific cases where the FDA used USP standards as evidence to seize adulterated substances and prosecute their manufacturers. To explore additional notices of judgment visit the FDA Notices of Judgment Collection on the National Library of Medicine website.
Published Oct 7, 2010
US v. Charles E. Lloyd for Adulteration of Solution of Citrate of Magnesia, September 26, 1917